Your session is about to expire
← Back to Search
Gentamicin-Based Irrigation for Sepsis
Phase 2
Waitlist Available
Led By Piruz Motamedinia, M.D.
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 30 days of surgery
Awards & highlights
Study Summary
This trial tests if a gentamicin-based fluid can reduce infections after surgery using ureteroscopy.
Who is the study for?
This trial is for adults needing surgery for kidney stones who can consent and follow the study plan. They must have had a positive urine culture treated with antibiotics, use effective contraception, and be at higher risk of post-surgery infection due to past UTIs or complications. Excluded are those with poor kidney function, pregnant or breastfeeding women, allergies to gentamicin, recent IV gentamicin use, or certain ear-related health issues.Check my eligibility
What is being tested?
The study tests if using gentamicin in the irrigation fluid during ureteroscopy can lower post-operative infections compared to a placebo. Participants will undergo standard procedures like cystoscopy and possible laser lithotripsy while being monitored for urinary tract infections (UTIs).See study design
What are the potential side effects?
Gentamicin may cause side effects such as allergic reactions in some people. It's also associated with potential risks like kidney damage (nephrotoxicity), hearing loss (ototoxicity), and dizziness but these are closely monitored during the trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 30 days of surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 30 days of surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Symptomatic urinary tract infection
Secondary outcome measures
Patient self-reported symptoms
Re-admission to hospital
Urosepsis
Side effects data
From 2013 Phase 4 trial • 614 Patients • NCT0092679640%
Nausea
22%
Diarrhea
14%
Vomiting
100%
80%
60%
40%
20%
0%
Study treatment Arm
Regimen B: Gemifloxacin Plus Azithromycin
Regimen A: Gentamicin Plus Azithromycin
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Gentamicin-Based IrrigationExperimental Treatment1 Intervention
This group will receive 120 mg of Gentamicin in 3 L NaCl as irrigation fluid during ureteroscopy
Group II: 3 L NaCl IrrigationPlacebo Group1 Intervention
This group will receive the typical NaCl irrigation used during ureteroscopy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gentamicin
2015
Completed Phase 4
~1110
Find a Location
Who is running the clinical trial?
Yale UniversityLead Sponsor
1,847 Previous Clinical Trials
2,737,256 Total Patients Enrolled
4 Trials studying Sepsis
144 Patients Enrolled for Sepsis
Piruz Motamedinia, M.D.Principal InvestigatorYale School of Medicine, Department of Urology
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Has the FDA sanctioned Gentamicin-Based Irrigation as an acceptable treatment?
"The safety of Gentamicin-Based Irrigation was appraised as a 2 on the scale from 1 to 3, as clinical data has been collected for its safety but not yet efficacy."
Answered by AI
Are there still open vacancies for participants in this medical trial?
"Clinicaltrials.gov showcases that this research project, which was launched on September 1st 2023 and last edited August 17th 2023 has stopped recruiting patients. Nevertheless, there are currently 288 other clinical trials enrolling participants right now."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger